Prostate tumors can differ significantly even within the same patient, reports Hannelore V. Heemers, PhD. When a patient has multiple tumors and only the largest one is analyzed using genomic fingerprinting, a smaller but more aggressive tumor may go undetected. Your doctor should consider this when using genomic fingerprinting for prostate cancer treatment.

Source: Bottom Line Personal February 1, 2017 Hannelore V. Heemers, PhD, is associate staff in the department of cancer biology at Lerner Research Institute. Cleveland Clinic. She is lead author of a study published in European Urology

PLEASE REMEMBER TO DONATE   THANK YOU!